Abstract:Highlights • This work examined the role for FUNDC1, a mitophagy receptor, in carbon tetrachloride (CCl4)-induced liver injury. CCl4 treatment induced excess production of mitochondrial ROS and overactivated mitophagy. We found that FUNDC1 is a culprit in eliciting ferroptosis but not in mitophagy activation, offering new insights for FUNDC1 function beyond mitophagy. • FUNDC1 interacted directly with glutathione peroxidase (GPx4), a selenoenzyme to neutralize lipid hydroperoxides and ferroptosis, via its 96-133 amino acid domain to facilitate GPx4 recruitment into mitochondria from cytoplasm. • GPx4 entered mitochondria through mitochondrial protein import system – the translocase of outer membrane / translocase of inner membrane (TOM/TIM) complex, prior to degradation of GPx4 mainly through mitophagy along with ROS-induced damaged mitochondria, resulting in hepatocyte ferroptosis. Introduction Liver fibrosis is a life-threatening pathological anomaly which usually evolves into advanced liver cirrhosis and hepatocellular carcinoma although limited therapeutic option is readily available. FUN14 domain containing 1 (FUNDC1) is a mitophagy receptor with little information in liver fibrosis. Objective This study was designed to examine the role for FUNDC1 in carbon tetrachloride (CCl4)-induced liver injury. Methods GEO database analysis and subsequent validation of biological processes including western blot, immunofluorescence, and co-immunoprecipitation were applied to clarify the regulatory role of FUNDC1 on mitophagy and ferroptosis. Results Our data revealed elevated FUNDC1 levels in liver tissues of patients with liver fibrotic injury and CCl4-challenged mice. FUNDC1 deletion protected against CCl4-induced hepatic anomalies in mice. Moreover, FUNDC1 deletion ameliorated CCl4-induced ferroptosis in vivo and in vitro. Mechanically, FUNDC1 interacted with glutathione peroxidase (GPx4), a selenoenzyme to neutralize lipid hydroperoxides and ferroptosis, via its 96-133 amino acid domain to facilitate GPx4 recruitment into mitochondria from cytoplasm. GPx4 entered mitochondria through mitochondrial protein import system-the translocase of outer membrane/translocase of inner membrane (TOM/TIM) complex, prior to degradation of GPx4 mainly through mitophagy along with ROS-induced damaged mitochondria, resulting in hepatocyte ferroptosis. Conclusion Taken together, our data favored that FUNDC1 promoted hepatocyte injury through GPx4 binding to facilitate its mitochondrial translocation through TOM/TIM complex, where GPx4 was degraded by mitophagy to trigger ferroptosis. Targeting FUNDC1 may be a promising therapeutic approach for liver fibrosis. Graphical abstract FUNDC1 promotes liver fibrosis and hepatic injury through direct binding to GPx4 to facilitate its mitochondrial translocation through TOM/TIM complex, where it is degraded along with the ROS-induced damaged mitochondria by mitophagy, resulting in hepatic ferroptosis. Download : Download high-res image (144KB) Download : Download full-size image

FUNDC1-mediated mitophagy suppresses hepatocarcinogenesis by inhibition of inflammasome activation.

FUNDC2 Promotes Liver Tumorigenesis by Inhibiting MFN1-mediated Mitochondrial Fusion

Zinc Finger Protein 296 Promotes Hepatocellular Carcinoma Progression Via Intervening Interaction Between Macrophages and B Cells.

FUNDC1 Interacts with GPx4 to Govern Hepatic Ferroptosis and Fibrotic Injury through a Mitophagy-Dependent Manner

The mitophagy effector FUNDC1 controls mitochondrial reprogramming and cellular plasticity in cancer cells

FUNDC1 modulates mitochondrial defects and pancreatic β-cell dysfunction under lipotoxicity

Deletion of Ifn Gamma Enhances Hepatocarcinogenesis in Fxr Knockout Mice

Mitochondrial Outer-Membrane Protein FUNDC1 Mediates Hypoxia-Induced Mitophagy in Mammalian Cells

Tumor Necrosis Factor-Α Promotes Hepatocellular Carcinogenesis Through the Activation of Hepatic Progenitor Cells.

FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production

Distinct Role of Interleukin-6 and Tumor Necrosis Factor Receptor-1 in Oval Cell- Mediated Liver Regeneration and Inflammation-Associated Hepatocarcinogenesis

Abstract 19194: FUNDC1 Regulates Mitochondrial Dynamics to Participate in High Fat Diet-Induced Cardiomyopathy

FUNDC1: A Promising Mitophagy Regulator at the Mitochondria-Associated Membrane for Cardiovascular Diseases

High expression of FUNDC1 predicts poor prognostic outcomes and is a promising target to improve chemoradiotherapy effects in patients with cervical cancer

The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation

Data from Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma Via Promoting T- and NK-cell Activation

Abstract 3858: Inflammation and Oncogene in Hepatocellular Carcinoma: Clinical Relevance and Experimental Targeted Therapy

ZNT1 and Zn 2+ control TLR4 and PD-L1 endocytosis in macrophages to improve chemotherapy efficacy against liver tumor

FUNDC1 Protects Against Doxorubicin-Induced Cardiomyocyte PANoptosis Through Stabilizing Mtdna Via Interaction with TUFM

FUNDC1/USP15/Drp1 ameliorated TNF-α–induced pulmonary artery endothelial cell proliferation by regulating mitochondrial dynamics

FUN14 Domain Containing 1 (FUNDC1): A Promising Mitophagy Receptor Regulating Mitochondrial Homeostasis in Cardiovascular Diseases